Page 1

Global Anticoccidial Drugs Market was Valued at US$ 1,592.3 Mn in 2018, Increase in the Prevalence of Coccidiosis in Animals Analyst Speak: “The Global Anticoccidial Drugs Market was valued around US$ 1,592.3 Mn in 2018 and expected to

surge at significant CAGR over the forecast period 2019-2025 owing to rise in prevalence of coccidiosis in animals around the globe” Precision Business Insights (PBI) in its report titled “Global Anticoccidial Drugs Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over eight years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. The global anticoccidial drugs market was valued at US$ 1,592.3 Mn in 2018 and anticipated to grow at significant CAGR over the forecast years due to increase in the livestock adoption rate, grow in prevalence of coccidiosis among the livestock species, rise in veterinary healthcare expenditure, and grow in demand for pet insurance. Moreover, growth in R&D for the development of newer therapeutics for coccidiosis, government support for the livestock farmers, and grow in demand for quality meat and other livestock products are projected to boost the global anticoccidial drugs market. However, stringent regulatory guidelines for the product approval, lack awareness about coccidiosis in underdeveloped countries, and high cost of drugs are anticipated to hamper the global anticoccidial drugs market over forecast years. Global anticoccidial drugs market segmented on the basis of drug type, animal type, distribution channel, and region Request Sample Report : https://www.precisionbusinessinsights.com/request-sample?product_id=16980

Ionophores accounted for higher revenue share Based on drug type, global anticoccidial drugs market segmented into sulpha drugs, amprolium, quinolones, ionophores, and others. Among all the drugs, ionophores accounted for higher revenue share in 2018 and estimated to lead the market over forecast years due to its broad-spectrum of activity against majority of pathogenic species of coccidian coupled with lack of drug resistance development among the animals. Moreover, launch of generics into market also surge the segment in the near future. For instance, in July 2019, Huvepharma EOOD received FDA approval for Monovet 90 the first generic monensin, an ionophore use in cattle fed to improve feed efficiency and prevention and control of coccidiosis

North America Dominated the Global Anticoccidial Drugs market PBI’s global anticoccidial drugs market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America dominated the anticoccidial drugs market from 2014-2018 and the same trend is expected to follow over 2019-2025 owing to animal adoption rate in USA and Canada, surge in R&D for the development of newer drugs, and increase in veterinary healthcare expenditure in the region. Europe projected to exhibit lucrative opportunities over the forecast years owing to adoption of advanced therapeutics in Germany, France, and UK, increase in awareness about the veterinary, and presence of huge number of market players in the region.


Launch of newer products, frequent product approvals, and strategic alliances are the key strategies adopted by market players Global Anticoccidial Drugs market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance. In April 2019, Creative Diagnostics launched innovative anticoccidial drug analysis products including Clopidol, Decoquinate, Diclazuril, Dinitolmide, Lasalocid, Maduramicin, Mebendazole, and so on for its customers across the globe Key player’s profiles in the report are Merial Life Sciences, Novartis Animal Healthc, Ceva Santé Animale, Boehringer Ingelheim Vetmedica, Virbac SA, Zoetis, Inc.m, Smartvet Inc., Biopredic, Intas, Dosch Pharma and Jurox

Detailed Segmentation By Drug Type o o o o o

Sulpha drugs Amprolium Quinolones Ionophores Others

By Animal Type o o o o o o o o o o

Feline Canine Equine Swine Poultry Beef Cattle Ruminants Aquaculture Others

By Distribution Channel o Veterinary Hospitals o Online Pharmacies o Retail Pharmacies

Geography o North America

 

USA Canada

o Europe

      

Germany UK France Russia Spain Italy Rest of Europe


o Asia-Pacific

    

China Japan India ASEAN Rest of Asia Pacific

o Latin America

   

Brazil Mexico Argentina Rest of Latin America

o Middle East and Africa

   

South Africa Gulf Corporation Council Countries (GCC) Rest of MEA

For More Information:

https://www.precisionbusinessinsights.com/market-reports/global-anticoccidial-drugs-market/

About Us: Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights. Contact Us: Shreya Paul Senior Business Development Executive Email @ shreya@precisionbusinessinsights.com Call @ +1-866-598-1553 Precision Business Insights Toll Free (US): +1-866-598-1553 Website @ https://www.precisionbusinessinsights.com


Profile for akhila reddy

Anticoccidial Drugs Market was Valued at US$ 1,592.3 Mn in 2018  

Global Anticoccidial Drugs Market was Valued at US$ 1,592.3 Mn in 2018, Increase in the Prevalence of Coccidiosis in Animals

Anticoccidial Drugs Market was Valued at US$ 1,592.3 Mn in 2018  

Global Anticoccidial Drugs Market was Valued at US$ 1,592.3 Mn in 2018, Increase in the Prevalence of Coccidiosis in Animals